Mary Mock, CDI.D ACE Board Candidate Appointed to Ethos Labs Advisory Board
Congratulations to Mary Mock for her appointment to the Ethos Labs Advisory Board. Mary's Board appointment is the 81st for ACE Graduates.
FOR RELEASE – December 12, 2022 -- Denver, CO
ACE LLC Announces the board appointment of ACE Graduate, Mary Mock, CDI.D to Ethos Labs Advisory Board.
Ethos Labs is a CAP accredited, CLIA certified, high-complexity laboratory that specializes in clinical toxicology, pain biomarker testing, pharmacogenetics, serology, and COVID-19 testing. Clinical diagnostic testing helps providers screen for or monitor specific medications, conditions, infections, diseases and more.
Read more HERE.
About Mary:
Mary Tracy Mock is a strategic, results-oriented executive with more than 30 years of experience leading healthcare firms with revenues of $15M - $90M. Extensive understanding of health care delivery systems including tele-health, value based care programs, financial and clinical reporting, provider network development and contracting, benefit design and rate development, resulting in seamless member and provider engagement, driving appropriate use value (both cost and quality) enhanced delivery of health care services.
Congratulations Ethos Labs for electing Mary Mock to your Advisory Board. We know she will bring value and serve the board, company and stakeholders well.
Mary has her board certification from Corporate Directors International LLC, USA. Her designation, CDI.D, recognizes her as a qualified corporate board candidate for a public or private board.